Concepedia

Peter Ruane

PR

Statistics

Publications

78

Citations

12.9K

H-Index

48

Active since

1985

Affiliations

Ruane Medical(Current)

Gilead Sciences (United States)

Orlando Immunology Center

Université Paris Cité

University of California San Diego

Peter Ruane is an author at Ruane Medical specializing in antiviral therapy, pharmacotherapy, and antiviral pharmacotherapy.

ORCID

Publications per year

1985–2024

78

Publications

78

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

, , +17

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 850 citations · Full text

, , +17

Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

Sharon Walmsley, Barry Bernstein, Martin King et al. · New England Journal of Medicine · 2002 · 650 citations

, , +17

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Bonaventura Clotet, Nicholas Bellos, Jean‐Michel Molina et al. · The Lancet · 2007 · 480 citations

, , +11

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Susanna Naggie, Curtis Cooper, Michael S. Saag et al. · New England Journal of Medicine · 2015 · 467 citations · Full text

, , +17

1–5 of 78